Aerosol-generating procedure

From WikiMD's WELLNESSPEDIA

  1. Aerosol-generating procedure

An aerosol-generating procedure (AGP) is a medical or dental procedure that can result in the release of airborne particles (aerosols) from the respiratory tract. These procedures are of particular concern in the context of infectious diseases, such as COVID-19, where aerosols may contain pathogens that can be transmitted through the air.

Overview[edit]

Aerosol-generating procedures are significant in healthcare settings because they can increase the risk of airborne transmission of infectious agents. During these procedures, small droplets and particles are generated, which can remain suspended in the air for extended periods and be inhaled by healthcare workers or other patients.

Common Aerosol-generating Procedures[edit]

Some common aerosol-generating procedures include:

Risks and Precautions[edit]

Healthcare workers performing AGPs are at increased risk of exposure to airborne pathogens. To mitigate these risks, several precautions are recommended:

Impact of COVID-19[edit]

The COVID-19 pandemic has heightened awareness of the risks associated with AGPs. The SARS-CoV-2 virus, responsible for COVID-19, can be transmitted via aerosols, making AGPs particularly concerning. Guidelines from organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) emphasize the importance of protective measures during AGPs to prevent the spread of COVID-19.

Research and Developments[edit]

Ongoing research aims to better understand the dynamics of aerosol generation and transmission during medical procedures. Innovations in PPE, ventilation systems, and procedural techniques continue to evolve to enhance safety for healthcare workers and patients.

Also see[edit]

Template:Infection control


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.